Business · 10/11/2020

FDA Announces Revised Guidance on Prescription Drug User Fees

The Food and Drug Administration (FDA) has released a revised final guidance on assessing user fees under the Prescription Drug User Fee Amendments of 2017, which supersedes the withdrawn May 2018 guidance and removes a fee exception for certain prescription drugs.